Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2900 of 3546 entries
View as:

Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women

Phase: N/A Priority: Normal
NCT ID: NCT02377414 Org: User:
Start: 03/02/15 End: 04/17/15 Due: 04/17/16

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00316706 Org: User:
Start: 10/31/05 End: 01/31/09 Due: 01/31/10

This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa

Phase: N/A Priority: Normal
NCT ID: NCT02052661 Org: User:
Start: 02/18/14 End: 09/23/14 Due: 09/23/15

A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01202201 Org: User:
Start: 09/30/10 End: 02/28/11 Due: 02/28/12

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children

Phase: N/A Priority: Normal
NCT ID: NCT00972517 Org: User:
Start: 09/29/09 End: 11/22/10 Due: 11/22/11

Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01248988 Org: User:
Start: 12/31/10 End: 09/30/15 Due: 09/30/16

Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia

Phase: N/A Priority: Normal
NCT ID: NCT01236066 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent

Phase: N/A Priority: Normal
NCT ID: NCT02689206 Org: User:
Start: 02/17/16 End: 01/25/17 Due: 01/25/18

A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae

Phase: N/A Priority: Normal
NCT ID: NCT02294682 Org: User:
Start: 04/15/15 End: 07/27/16 Due: 07/27/17

A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02006537 Org: User:
Start: 01/31/14 End: 05/27/14 Due: 05/27/15

Ispinesib In Combination With Carboplatin In Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00136578 Org: User:
Start: 10/20/04 End: 10/25/06 Due: 10/25/07

Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations

Phase: N/A Priority: Normal
NCT ID: NCT02446691 Org: User:
Start: 07/13/15 End: 12/28/17 Due: 12/28/18

GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00291356 Org: User:
Start: 01/31/06 End: 05/31/06 Due: 05/31/07

Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02221037 Org: User:
Start: 04/28/15 End: 06/28/17 Due: 06/28/18

Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2

Phase: N/A Priority: Normal
NCT ID: NCT02119286 Org: User:
Start: 10/31/13 End: 04/30/14 Due: 04/30/15

Prevention of Seasonal Affective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00046449 Org: User:
Start: 09/30/02 End: 06/30/03 Due: 06/30/04

Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants

Phase: N/A Priority: Normal
NCT ID: NCT00158756 Org: User:
Start: 09/12/05 End: 11/23/06 Due: 11/23/07

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT01013766 Org: User:
Start: 08/13/09 End: 11/20/09 Due: 11/20/10

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Phase: N/A Priority: Normal
NCT ID: NCT00601172 Org: User:
Start: 03/10/08 End: 04/13/09 Due: 04/13/10

A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced

Phase: N/A Priority: Normal
NCT ID: NCT01453478 Org: User:
Start: 10/12/11 End: 12/19/11 Due: 12/19/12

A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00742508 Org: User:
Start: 08/28/08 End: 08/21/09 Due: 08/21/10

An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain

Phase: N/A Priority: Normal
NCT ID: NCT01205412 Org: User:
Start: 10/31/10 End: 11/30/11 Due: 11/30/12

Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02729038 Org: User:
Start: 06/29/16 End: 06/20/17 Due: 06/20/18

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT01878812 Org: User:
Start: 07/11/13 End: 08/05/13 Due: 08/05/14

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT00984139 Org: User:
Start: 10/12/09 End: 04/07/10 Due: 04/07/11